Search

Displaying results 31 - 40 of 78 in total
  1. Indication

    Recurrent Cutaneous Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0144328
    Drugs: Pembrolizumab
  2. Indication

    Refractory Classical Hodgkin's Lymphoma

    go.drugbank.com/conditions/DBCOND0144296
    Drugs: Pembrolizumab
  3. Indication

    Stage 1b Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173418
    Drugs: Pembrolizumab
  4. Indication

    Unresectable, locally advanced HER2 negative Gastric Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0162413
    Drugs: Pembrolizumab
  5. Indication

    Unresectable, locally advanced HER2-positive Adenocarcinomas of the Gastroesophageal Junction

    go.drugbank.com/conditions/DBCOND0144314
    Drugs: Pembrolizumab
  6. Indication

    Clear Cell Renal Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0029155
    Drugs: Belzutifan · Pembrolizumab
  7. Indication

    Metastatic Merkel Cell Carcinoma (MCC)

    go.drugbank.com/conditions/DBCOND0093764
    Drugs: Avelumab · Pembrolizumab
  8. Indication

    Recurrent, locally advanced Merkel Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0144323
    Drugs: Pembrolizumab · Retifanlimab
  9. Indication

    Relapsed Classical Hodgkin's Lymphoma

    go.drugbank.com/conditions/DBCOND0144295
    Drugs: Nivolumab · Pembrolizumab
  10. Indication

    Unresectable Mismatch Repair Deficient Colorectal Cancer

    go.drugbank.com/conditions/DBCOND0144309
    Drugs: Nivolumab · Pembrolizumab